Consequently, the present study has been designed to estimate whether MDM2 rs2279744 or TP53 rs1042522 polymorphism confers risk to cervical cancer susceptibility and provide support for future research of gene-gene interaction in cervical cancer. The gene discussed is TP53; the disease is cervical cancer.